| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
SMCAP: VAPH |
| Security Type |
Class A Common Shares |
| Lead Underwriter |
Kashner Davidson Securities |
| Days In Registration |
159 |
| Date Filed |
3-Jul-2003 |
| Form Filed | S-B2 |
Fundamentals
(Year Ending December 2008) |
| Industry |
Manufacturing |
| Business Description |
Manufacture prescription pharmaceuticals intended for final consumption, including biotech products and antibiotics |
| Revenue |
$0.1M |
| Net Income |
-$1.7M |
| Shares Outstanding (post-offering) |
3.0M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
1.2M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
1.2M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
130.0K |
| File Amount |
$6.0M |
| File Price Range |
$5.00 - $5.00 |
| File Mid Price |
$5.00 |
Current Filing Information
(Amended 9-Dec-2003) |
|
US |
|
Shares Filed |
1.3M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
1.3M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$6.5M |
| · % Change from Original |
8.33 |
| File Price Range |
$5.00 - $5.00 |
| File Mid Price |
$5.00 |
|
